University of Zurich: Coronary Artery Disease trials
The registry lists 13 Coronary Artery Disease studies with University of Zurich as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 4 1No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot StudyNot yet recruitingNCT07421947Not applicable
- Deep-Learning Image Reconstruction in CCTACompletedNCT03980470Not applicableResults posted
- Ultra Low Dose CT for CACS and AC of SPECTCompletedNCT02458352Not applicableResults posted
- Complementary Investigation of Perfusion and Anatomy Measures of the Heart With MRI and Combined PET/MRICompletedNCT05609214
- Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI TrialActive, not recruitingNCT04310046Not applicable
- Ultra-low-dose CACS in a Large PopulationTerminatedNCT03637231Not applicable
- MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI TrialCompletedNCT03135275Not applicable
- Dynamic CT Myocardial Perfusion ImagingTerminatedNCT02593838Not applicable
- Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery DiseaseCompletedNCT02520466Not applicable
- Breath-hold Cardiac Hybrid SPECT/CCTACompletedNCT02469051Not applicable
- Pycnogenol and Endothelial Function in Coronary Artery DiseaseCompletedNCT00641758Not applicable
- Paracetamol and Endothelial Function in Patients With Stable Coronary Artery DiseaseCompletedNCT00534651Phase 4
- Effect of Eplerenone on Endothelial Function in Patients With Stable Coronary Heart DiseaseCompletedNCT00427284